Cargando…
Effects of Serum Albumin Levels on Antithrombin Supplementation Outcomes Among Patients With Sepsis-Associated Coagulopathy: A Retrospective Study
BACKGROUND: Severe sepsis is commonly associated with mortality among critically ill patients and is known to cause coagulopathy. While antithrombin is an anticoagulant used in this setting, serum albumin levels are known to influence serum antithrombin levels. Therefore, this study aimed to evaluat...
Autores principales: | Ebina, Masatomo, Fujino, Kazunori, Inoue, Akira, Ariyoshi, Koichi, Eguchi, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589945/ https://www.ncbi.nlm.nih.gov/pubmed/31258337 http://dx.doi.org/10.1177/1179545X19858361 |
Ejemplares similares
-
Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin
por: Iba, Toshiaki, et al.
Publicado: (2018) -
Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998) -
Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy
por: Wiedermann, Christian J.
Publicado: (2022) -
Impact of Antithrombin Supplementation and Concomitant Anticoagulation
Therapy in Pediatric Patients With Disseminated Intravascular Coagulation
por: Nagafuchi, Hiroyuki, et al.
Publicado: (2019) -
Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005)